nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfadiazine—CYP2E1—type 2 diabetes mellitus	0.153	0.614	CbGaD
Sulfadiazine—CYP3A4—type 2 diabetes mellitus	0.0966	0.386	CbGaD
Sulfadiazine—Sulfacetamide—Tolazamide—type 2 diabetes mellitus	0.0737	0.266	CrCrCtD
Sulfadiazine—Sulfacetamide—Tolbutamide—type 2 diabetes mellitus	0.0698	0.252	CrCrCtD
Sulfadiazine—Sulfacetamide—Gliclazide—type 2 diabetes mellitus	0.0698	0.252	CrCrCtD
Sulfadiazine—Sulfacetamide—Chlorpropamide—type 2 diabetes mellitus	0.0639	0.231	CrCrCtD
Sulfadiazine—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0266	0.0758	CbGbCtD
Sulfadiazine—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0212	0.0606	CbGbCtD
Sulfadiazine—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0192	0.0548	CbGbCtD
Sulfadiazine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0185	0.0529	CbGbCtD
Sulfadiazine—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0177	0.0506	CbGbCtD
Sulfadiazine—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0171	0.0489	CbGbCtD
Sulfadiazine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0169	0.0484	CbGbCtD
Sulfadiazine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0158	0.045	CbGbCtD
Sulfadiazine—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.014	0.0398	CbGbCtD
Sulfadiazine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0134	0.0382	CbGbCtD
Sulfadiazine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0134	0.0382	CbGbCtD
Sulfadiazine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0124	0.0353	CbGbCtD
Sulfadiazine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0121	0.0345	CbGbCtD
Sulfadiazine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0119	0.0341	CbGbCtD
Sulfadiazine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0109	0.0312	CbGbCtD
Sulfadiazine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0108	0.0307	CbGbCtD
Sulfadiazine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0102	0.029	CbGbCtD
Sulfadiazine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00985	0.0281	CbGbCtD
Sulfadiazine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00973	0.0278	CbGbCtD
Sulfadiazine—CYP2C8—Losartan—type 2 diabetes mellitus	0.00899	0.0257	CbGbCtD
Sulfadiazine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00861	0.0246	CbGbCtD
Sulfadiazine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00779	0.0222	CbGbCtD
Sulfadiazine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00686	0.0196	CbGbCtD
Sulfadiazine—CYP2C9—Losartan—type 2 diabetes mellitus	0.00627	0.0179	CbGbCtD
Sulfadiazine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0059	0.0168	CbGbCtD
Sulfadiazine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00566	0.0162	CbGbCtD
Sulfadiazine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00566	0.0162	CbGbCtD
Sulfadiazine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00535	0.0153	CbGbCtD
Sulfadiazine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00399	0.0114	CbGbCtD
Sulfadiazine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00365	0.0104	CbGbCtD
Sulfadiazine—Glycodiazine—ABCC8—type 2 diabetes mellitus	0.00101	0.394	CrCbGaD
Sulfadiazine—Sulfisoxazole—EDNRA—type 2 diabetes mellitus	0.000527	0.205	CrCbGaD
Sulfadiazine—Sulfasalazine—PPARG—type 2 diabetes mellitus	0.00015	0.0583	CrCbGaD
Sulfadiazine—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000148	0.0015	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Sitagliptin—type 2 diabetes mellitus	0.000146	0.00149	CcSEcCtD
Sulfadiazine—Sulfasalazine—ABCC2—type 2 diabetes mellitus	0.000146	0.0569	CrCbGaD
Sulfadiazine—Leukopenia—Glyburide—type 2 diabetes mellitus	0.000146	0.00148	CcSEcCtD
Sulfadiazine—Insomnia—Glimepiride—type 2 diabetes mellitus	0.000146	0.00148	CcSEcCtD
Sulfadiazine—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.000145	0.00148	CcSEcCtD
Sulfadiazine—Nausea—Nateglinide—type 2 diabetes mellitus	0.000143	0.00146	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000143	0.00145	CcSEcCtD
Sulfadiazine—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000143	0.00145	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.000141	0.00144	CcSEcCtD
Sulfadiazine—Convulsion—Glyburide—type 2 diabetes mellitus	0.000141	0.00144	CcSEcCtD
Sulfadiazine—Hepatitis—Metformin—type 2 diabetes mellitus	0.000141	0.00143	CcSEcCtD
Sulfadiazine—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.00014	0.00143	CcSEcCtD
Sulfadiazine—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.00014	0.00142	CcSEcCtD
Sulfadiazine—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.00014	0.00142	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Ramipril—type 2 diabetes mellitus	0.000139	0.00142	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000139	0.00142	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000139	0.00141	CcSEcCtD
Sulfadiazine—Arthralgia—Glyburide—type 2 diabetes mellitus	0.000139	0.00141	CcSEcCtD
Sulfadiazine—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.000139	0.00141	CcSEcCtD
Sulfadiazine—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.000138	0.0014	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Losartan—type 2 diabetes mellitus	0.000138	0.0014	CcSEcCtD
Sulfadiazine—Urticaria—Glipizide—type 2 diabetes mellitus	0.000137	0.0014	CcSEcCtD
Sulfadiazine—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000137	0.00139	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Losartan—type 2 diabetes mellitus	0.000136	0.00139	CcSEcCtD
Sulfadiazine—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000135	0.00137	CcSEcCtD
Sulfadiazine—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000133	0.00135	CcSEcCtD
Sulfadiazine—Hepatitis—Irbesartan—type 2 diabetes mellitus	0.000133	0.00135	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000132	0.00134	CcSEcCtD
Sulfadiazine—Rash—Repaglinide—type 2 diabetes mellitus	0.000132	0.00134	CcSEcCtD
Sulfadiazine—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000132	0.00134	CcSEcCtD
Sulfadiazine—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000132	0.00134	CcSEcCtD
Sulfadiazine—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000132	0.00134	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000131	0.00134	CcSEcCtD
Sulfadiazine—Pancreatitis—Ramipril—type 2 diabetes mellitus	0.000131	0.00133	CcSEcCtD
Sulfadiazine—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000131	0.00133	CcSEcCtD
Sulfadiazine—Headache—Repaglinide—type 2 diabetes mellitus	0.000131	0.00133	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.00013	0.00133	CcSEcCtD
Sulfadiazine—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.00013	0.00132	CcSEcCtD
Sulfadiazine—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000128	0.0013	CcSEcCtD
Sulfadiazine—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000128	0.0013	CcSEcCtD
Sulfadiazine—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000127	0.0013	CcSEcCtD
Sulfadiazine—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000127	0.0013	CcSEcCtD
Sulfadiazine—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000127	0.00129	CcSEcCtD
Sulfadiazine—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000127	0.00129	CcSEcCtD
Sulfadiazine—Anorexia—Glyburide—type 2 diabetes mellitus	0.000127	0.00129	CcSEcCtD
Sulfadiazine—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000126	0.00129	CcSEcCtD
Sulfadiazine—Chills—Metformin—type 2 diabetes mellitus	0.000126	0.00128	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000126	0.00128	CcSEcCtD
Sulfadiazine—Hepatitis—Losartan—type 2 diabetes mellitus	0.000125	0.00127	CcSEcCtD
Sulfadiazine—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.000125	0.00127	CcSEcCtD
Sulfadiazine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000124	0.00127	CcSEcCtD
Sulfadiazine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000124	0.00127	CcSEcCtD
Sulfadiazine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000124	0.00126	CcSEcCtD
Sulfadiazine—Tinnitus—Irbesartan—type 2 diabetes mellitus	0.000124	0.00126	CcSEcCtD
Sulfadiazine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000124	0.00126	CcSEcCtD
Sulfadiazine—Pruritus—Glipizide—type 2 diabetes mellitus	0.000122	0.00124	CcSEcCtD
Sulfadiazine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000122	0.00124	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000121	0.00123	CcSEcCtD
Sulfadiazine—Vertigo—Valsartan—type 2 diabetes mellitus	0.000121	0.00123	CcSEcCtD
Sulfadiazine—Vertigo—Orlistat—type 2 diabetes mellitus	0.000119	0.00121	CcSEcCtD
Sulfadiazine—Chills—Irbesartan—type 2 diabetes mellitus	0.000119	0.00121	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000119	0.00121	CcSEcCtD
Sulfadiazine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000119	0.00121	CcSEcCtD
Sulfadiazine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000118	0.00121	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.000118	0.0012	CcSEcCtD
Sulfadiazine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000118	0.0012	CcSEcCtD
Sulfadiazine—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000118	0.0012	CcSEcCtD
Sulfadiazine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000117	0.00119	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Ramipril—type 2 diabetes mellitus	0.000117	0.00119	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000117	0.00119	CcSEcCtD
Sulfadiazine—Tinnitus—Losartan—type 2 diabetes mellitus	0.000116	0.00119	CcSEcCtD
Sulfadiazine—Stomatitis—Ramipril—type 2 diabetes mellitus	0.000116	0.00118	CcSEcCtD
Sulfadiazine—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000116	0.00118	CcSEcCtD
Sulfadiazine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000116	0.00118	CcSEcCtD
Sulfadiazine—Convulsion—Orlistat—type 2 diabetes mellitus	0.000115	0.00117	CcSEcCtD
Sulfadiazine—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000115	0.00117	CcSEcCtD
Sulfadiazine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000115	0.00117	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000115	0.00117	CcSEcCtD
Sulfadiazine—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000114	0.00116	CcSEcCtD
Sulfadiazine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000114	0.00116	CcSEcCtD
Sulfadiazine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000113	0.00115	CcSEcCtD
Sulfadiazine—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000111	0.00113	CcSEcCtD
Sulfadiazine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00011	0.00112	CcSEcCtD
Sulfadiazine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00011	0.00112	CcSEcCtD
Sulfadiazine—Sulfamethazine—ALB—type 2 diabetes mellitus	0.00011	0.0427	CrCbGaD
Sulfadiazine—Vomiting—Glipizide—type 2 diabetes mellitus	0.00011	0.00112	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.00011	0.00112	CcSEcCtD
Sulfadiazine—Rash—Glipizide—type 2 diabetes mellitus	0.000109	0.00111	CcSEcCtD
Sulfadiazine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000109	0.00111	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000109	0.00111	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000109	0.00111	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000108	0.0011	CcSEcCtD
Sulfadiazine—Headache—Glipizide—type 2 diabetes mellitus	0.000108	0.0011	CcSEcCtD
Sulfadiazine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000108	0.0011	CcSEcCtD
Sulfadiazine—Sulfamerazine—ALB—type 2 diabetes mellitus	0.000107	0.0418	CrCbGaD
Sulfadiazine—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000107	0.00109	CcSEcCtD
Sulfadiazine—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000107	0.00109	CcSEcCtD
Sulfadiazine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000106	0.00108	CcSEcCtD
Sulfadiazine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000105	0.00107	CcSEcCtD
Sulfadiazine—Anorexia—Valsartan—type 2 diabetes mellitus	0.000105	0.00106	CcSEcCtD
Sulfadiazine—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000104	0.00106	CcSEcCtD
Sulfadiazine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000104	0.00106	CcSEcCtD
Sulfadiazine—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000103	0.00105	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000103	0.00105	CcSEcCtD
Sulfadiazine—Nausea—Glipizide—type 2 diabetes mellitus	0.000103	0.00104	CcSEcCtD
Sulfadiazine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000103	0.00104	CcSEcCtD
Sulfadiazine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000102	0.00104	CcSEcCtD
Sulfadiazine—Rash—Glimepiride—type 2 diabetes mellitus	0.000102	0.00103	CcSEcCtD
Sulfadiazine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000102	0.00103	CcSEcCtD
Sulfadiazine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000101	0.00103	CcSEcCtD
Sulfadiazine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000101	0.00103	CcSEcCtD
Sulfadiazine—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000101	0.00103	CcSEcCtD
Sulfadiazine—Headache—Glimepiride—type 2 diabetes mellitus	0.000101	0.00103	CcSEcCtD
Sulfadiazine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000101	0.00102	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	9.99e-05	0.00102	CcSEcCtD
Sulfadiazine—Tinnitus—Ramipril—type 2 diabetes mellitus	9.98e-05	0.00102	CcSEcCtD
Sulfadiazine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	9.95e-05	0.00101	CcSEcCtD
Sulfadiazine—Insomnia—Valsartan—type 2 diabetes mellitus	9.92e-05	0.00101	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	9.88e-05	0.00101	CcSEcCtD
Sulfadiazine—Arthralgia—Irbesartan—type 2 diabetes mellitus	9.83e-05	0.001	CcSEcCtD
Sulfadiazine—Insomnia—Orlistat—type 2 diabetes mellitus	9.8e-05	0.000998	CcSEcCtD
Sulfadiazine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	9.8e-05	0.000997	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	9.78e-05	0.000996	CcSEcCtD
Sulfadiazine—Vertigo—Losartan—type 2 diabetes mellitus	9.77e-05	0.000994	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	9.76e-05	0.000994	CcSEcCtD
Sulfadiazine—Leukopenia—Losartan—type 2 diabetes mellitus	9.73e-05	0.00099	CcSEcCtD
Sulfadiazine—Nausea—Glimepiride—type 2 diabetes mellitus	9.58e-05	0.000975	CcSEcCtD
Sulfadiazine—Nausea—Sitagliptin—type 2 diabetes mellitus	9.55e-05	0.000972	CcSEcCtD
Sulfadiazine—Decreased appetite—Valsartan—type 2 diabetes mellitus	9.54e-05	0.000971	CcSEcCtD
Sulfadiazine—Anorexia—Metformin—type 2 diabetes mellitus	9.52e-05	0.000969	CcSEcCtD
Sulfadiazine—Urticaria—Gliclazide—type 2 diabetes mellitus	9.49e-05	0.000965	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	9.47e-05	0.000964	CcSEcCtD
Sulfadiazine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	9.44e-05	0.000961	CcSEcCtD
Sulfadiazine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	9.44e-05	0.000961	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	9.43e-05	0.00096	CcSEcCtD
Sulfadiazine—Decreased appetite—Orlistat—type 2 diabetes mellitus	9.42e-05	0.000959	CcSEcCtD
Sulfadiazine—Pruritus—Glyburide—type 2 diabetes mellitus	9.41e-05	0.000958	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	9.36e-05	0.000952	CcSEcCtD
Sulfadiazine—Arthralgia—Losartan—type 2 diabetes mellitus	9.26e-05	0.000942	CcSEcCtD
Sulfadiazine—Vomiting—Bromocriptine—type 2 diabetes mellitus	9.25e-05	0.000941	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	9.23e-05	0.000939	CcSEcCtD
Sulfadiazine—Rash—Bromocriptine—type 2 diabetes mellitus	9.17e-05	0.000933	CcSEcCtD
Sulfadiazine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	9.16e-05	0.000933	CcSEcCtD
Sulfadiazine—Headache—Bromocriptine—type 2 diabetes mellitus	9.11e-05	0.000927	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	9.1e-05	0.000926	CcSEcCtD
Sulfadiazine—Diarrhoea—Glyburide—type 2 diabetes mellitus	9.1e-05	0.000926	CcSEcCtD
Sulfadiazine—Anorexia—Irbesartan—type 2 diabetes mellitus	8.99e-05	0.000915	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	8.97e-05	0.000913	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	8.87e-05	0.000903	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	8.86e-05	0.000902	CcSEcCtD
Sulfadiazine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	8.8e-05	0.000895	CcSEcCtD
Sulfadiazine—Urticaria—Valsartan—type 2 diabetes mellitus	8.72e-05	0.000887	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	8.69e-05	0.000884	CcSEcCtD
Sulfadiazine—Decreased appetite—Metformin—type 2 diabetes mellitus	8.68e-05	0.000884	CcSEcCtD
Sulfadiazine—Abdominal pain—Valsartan—type 2 diabetes mellitus	8.67e-05	0.000883	CcSEcCtD
Sulfadiazine—Nausea—Bromocriptine—type 2 diabetes mellitus	8.64e-05	0.000879	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	8.62e-05	0.000878	CcSEcCtD
Sulfadiazine—Urticaria—Orlistat—type 2 diabetes mellitus	8.61e-05	0.000876	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	8.59e-05	0.000874	CcSEcCtD
Sulfadiazine—Body temperature increased—Orlistat—type 2 diabetes mellitus	8.57e-05	0.000872	CcSEcCtD
Sulfadiazine—Abdominal pain—Orlistat—type 2 diabetes mellitus	8.57e-05	0.000872	CcSEcCtD
Sulfadiazine—Anorexia—Losartan—type 2 diabetes mellitus	8.46e-05	0.000861	CcSEcCtD
Sulfadiazine—Vomiting—Glyburide—type 2 diabetes mellitus	8.45e-05	0.000861	CcSEcCtD
Sulfadiazine—Pruritus—Gliclazide—type 2 diabetes mellitus	8.45e-05	0.00086	CcSEcCtD
Sulfadiazine—Rash—Glyburide—type 2 diabetes mellitus	8.38e-05	0.000853	CcSEcCtD
Sulfadiazine—Dermatitis—Glyburide—type 2 diabetes mellitus	8.38e-05	0.000853	CcSEcCtD
Sulfadiazine—Vertigo—Ramipril—type 2 diabetes mellitus	8.38e-05	0.000852	CcSEcCtD
Sulfadiazine—Leukopenia—Ramipril—type 2 diabetes mellitus	8.34e-05	0.000849	CcSEcCtD
Sulfadiazine—Sulfamethizole—ALB—type 2 diabetes mellitus	8.33e-05	0.0324	CrCbGaD
Sulfadiazine—Headache—Glyburide—type 2 diabetes mellitus	8.33e-05	0.000848	CcSEcCtD
Sulfadiazine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	8.2e-05	0.000834	CcSEcCtD
Sulfadiazine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	8.17e-05	0.000831	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	8.17e-05	0.000831	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	8.14e-05	0.000828	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	8.08e-05	0.000823	CcSEcCtD
Sulfadiazine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	8.08e-05	0.000823	CcSEcCtD
Sulfadiazine—Convulsion—Ramipril—type 2 diabetes mellitus	8.08e-05	0.000822	CcSEcCtD
Sulfadiazine—Insomnia—Losartan—type 2 diabetes mellitus	8.02e-05	0.000817	CcSEcCtD
Sulfadiazine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	7.99e-05	0.000813	CcSEcCtD
Sulfadiazine—Urticaria—Metformin—type 2 diabetes mellitus	7.94e-05	0.000808	CcSEcCtD
Sulfadiazine—Arthralgia—Ramipril—type 2 diabetes mellitus	7.94e-05	0.000808	CcSEcCtD
Sulfadiazine—Nausea—Glyburide—type 2 diabetes mellitus	7.9e-05	0.000804	CcSEcCtD
Sulfadiazine—Abdominal pain—Metformin—type 2 diabetes mellitus	7.9e-05	0.000804	CcSEcCtD
Sulfadiazine—Pruritus—Valsartan—type 2 diabetes mellitus	7.76e-05	0.00079	CcSEcCtD
Sulfadiazine—Decreased appetite—Losartan—type 2 diabetes mellitus	7.71e-05	0.000785	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	7.71e-05	0.000785	CcSEcCtD
Sulfadiazine—Pruritus—Orlistat—type 2 diabetes mellitus	7.67e-05	0.000781	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	7.61e-05	0.000774	CcSEcCtD
Sulfadiazine—Vomiting—Gliclazide—type 2 diabetes mellitus	7.59e-05	0.000773	CcSEcCtD
Sulfadiazine—Rash—Gliclazide—type 2 diabetes mellitus	7.53e-05	0.000766	CcSEcCtD
Sulfadiazine—Dermatitis—Gliclazide—type 2 diabetes mellitus	7.52e-05	0.000766	CcSEcCtD
Sulfadiazine—Diarrhoea—Valsartan—type 2 diabetes mellitus	7.51e-05	0.000764	CcSEcCtD
Sulfadiazine—Urticaria—Irbesartan—type 2 diabetes mellitus	7.49e-05	0.000762	CcSEcCtD
Sulfadiazine—Headache—Gliclazide—type 2 diabetes mellitus	7.48e-05	0.000761	CcSEcCtD
Sulfadiazine—Sulfanilamide—CYP2E1—type 2 diabetes mellitus	7.47e-05	0.029	CrCbGaD
Sulfadiazine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	7.45e-05	0.000759	CcSEcCtD
Sulfadiazine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	7.45e-05	0.000759	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	7.45e-05	0.000758	CcSEcCtD
Sulfadiazine—Diarrhoea—Orlistat—type 2 diabetes mellitus	7.42e-05	0.000755	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	7.26e-05	0.000738	CcSEcCtD
Sulfadiazine—Anorexia—Ramipril—type 2 diabetes mellitus	7.25e-05	0.000738	CcSEcCtD
Sulfadiazine—Nausea—Gliclazide—type 2 diabetes mellitus	7.09e-05	0.000722	CcSEcCtD
Sulfadiazine—Pruritus—Metformin—type 2 diabetes mellitus	7.07e-05	0.000719	CcSEcCtD
Sulfadiazine—Urticaria—Losartan—type 2 diabetes mellitus	7.05e-05	0.000717	CcSEcCtD
Sulfadiazine—Body temperature increased—Losartan—type 2 diabetes mellitus	7.01e-05	0.000714	CcSEcCtD
Sulfadiazine—Abdominal pain—Losartan—type 2 diabetes mellitus	7.01e-05	0.000714	CcSEcCtD
Sulfadiazine—Vomiting—Valsartan—type 2 diabetes mellitus	6.98e-05	0.00071	CcSEcCtD
Sulfadiazine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	6.95e-05	0.000707	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	6.93e-05	0.000705	CcSEcCtD
Sulfadiazine—Rash—Valsartan—type 2 diabetes mellitus	6.92e-05	0.000704	CcSEcCtD
Sulfadiazine—Dermatitis—Valsartan—type 2 diabetes mellitus	6.91e-05	0.000703	CcSEcCtD
Sulfadiazine—Vomiting—Orlistat—type 2 diabetes mellitus	6.89e-05	0.000701	CcSEcCtD
Sulfadiazine—Insomnia—Ramipril—type 2 diabetes mellitus	6.88e-05	0.0007	CcSEcCtD
Sulfadiazine—Headache—Valsartan—type 2 diabetes mellitus	6.87e-05	0.000699	CcSEcCtD
Sulfadiazine—Diarrhoea—Metformin—type 2 diabetes mellitus	6.84e-05	0.000696	CcSEcCtD
Sulfadiazine—Rash—Orlistat—type 2 diabetes mellitus	6.83e-05	0.000696	CcSEcCtD
Sulfadiazine—Dermatitis—Orlistat—type 2 diabetes mellitus	6.83e-05	0.000695	CcSEcCtD
Sulfadiazine—Headache—Orlistat—type 2 diabetes mellitus	6.79e-05	0.000691	CcSEcCtD
Sulfadiazine—Pruritus—Irbesartan—type 2 diabetes mellitus	6.67e-05	0.000679	CcSEcCtD
Sulfadiazine—Dapsone—CYP2E1—type 2 diabetes mellitus	6.66e-05	0.0259	CrCbGaD
Sulfadiazine—Decreased appetite—Ramipril—type 2 diabetes mellitus	6.61e-05	0.000673	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	6.57e-05	0.000668	CcSEcCtD
Sulfadiazine—Hypersensitivity—Losartan—type 2 diabetes mellitus	6.54e-05	0.000665	CcSEcCtD
Sulfadiazine—Nausea—Valsartan—type 2 diabetes mellitus	6.52e-05	0.000663	CcSEcCtD
Sulfadiazine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6.45e-05	0.000657	CcSEcCtD
Sulfadiazine—Nausea—Orlistat—type 2 diabetes mellitus	6.44e-05	0.000655	CcSEcCtD
Sulfadiazine—Vomiting—Metformin—type 2 diabetes mellitus	6.35e-05	0.000646	CcSEcCtD
Sulfadiazine—Sulfasalazine—PTGS2—type 2 diabetes mellitus	6.34e-05	0.0246	CrCbGaD
Sulfadiazine—Rash—Metformin—type 2 diabetes mellitus	6.3e-05	0.000641	CcSEcCtD
Sulfadiazine—Dermatitis—Metformin—type 2 diabetes mellitus	6.29e-05	0.00064	CcSEcCtD
Sulfadiazine—Pruritus—Losartan—type 2 diabetes mellitus	6.28e-05	0.000639	CcSEcCtD
Sulfadiazine—Headache—Metformin—type 2 diabetes mellitus	6.26e-05	0.000637	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	6.22e-05	0.000633	CcSEcCtD
Sulfadiazine—Diarrhoea—Losartan—type 2 diabetes mellitus	6.07e-05	0.000618	CcSEcCtD
Sulfadiazine—Urticaria—Ramipril—type 2 diabetes mellitus	6.04e-05	0.000615	CcSEcCtD
Sulfadiazine—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.01e-05	0.000612	CcSEcCtD
Sulfadiazine—Body temperature increased—Ramipril—type 2 diabetes mellitus	6.01e-05	0.000612	CcSEcCtD
Sulfadiazine—Vomiting—Irbesartan—type 2 diabetes mellitus	5.99e-05	0.00061	CcSEcCtD
Sulfadiazine—Rash—Irbesartan—type 2 diabetes mellitus	5.94e-05	0.000605	CcSEcCtD
Sulfadiazine—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.94e-05	0.000604	CcSEcCtD
Sulfadiazine—Nausea—Metformin—type 2 diabetes mellitus	5.93e-05	0.000604	CcSEcCtD
Sulfadiazine—Headache—Irbesartan—type 2 diabetes mellitus	5.91e-05	0.000601	CcSEcCtD
Sulfadiazine—Vomiting—Losartan—type 2 diabetes mellitus	5.64e-05	0.000574	CcSEcCtD
Sulfadiazine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.61e-05	0.00057	CcSEcCtD
Sulfadiazine—Nausea—Irbesartan—type 2 diabetes mellitus	5.6e-05	0.00057	CcSEcCtD
Sulfadiazine—Rash—Losartan—type 2 diabetes mellitus	5.59e-05	0.000569	CcSEcCtD
Sulfadiazine—Dermatitis—Losartan—type 2 diabetes mellitus	5.59e-05	0.000569	CcSEcCtD
Sulfadiazine—Headache—Losartan—type 2 diabetes mellitus	5.56e-05	0.000566	CcSEcCtD
Sulfadiazine—Pruritus—Ramipril—type 2 diabetes mellitus	5.38e-05	0.000548	CcSEcCtD
Sulfadiazine—Sulfamethoxazole—CYP3A4—type 2 diabetes mellitus	5.36e-05	0.0208	CrCbGaD
Sulfadiazine—Nausea—Losartan—type 2 diabetes mellitus	5.27e-05	0.000536	CcSEcCtD
Sulfadiazine—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.21e-05	0.00053	CcSEcCtD
Sulfadiazine—Vomiting—Ramipril—type 2 diabetes mellitus	4.84e-05	0.000492	CcSEcCtD
Sulfadiazine—Rash—Ramipril—type 2 diabetes mellitus	4.8e-05	0.000488	CcSEcCtD
Sulfadiazine—Dermatitis—Ramipril—type 2 diabetes mellitus	4.79e-05	0.000488	CcSEcCtD
Sulfadiazine—Headache—Ramipril—type 2 diabetes mellitus	4.77e-05	0.000485	CcSEcCtD
Sulfadiazine—Sulfanilamide—CYP3A4—type 2 diabetes mellitus	4.7e-05	0.0183	CrCbGaD
Sulfadiazine—Sulfamethoxazole—ALB—type 2 diabetes mellitus	4.68e-05	0.0182	CrCbGaD
Sulfadiazine—Nausea—Ramipril—type 2 diabetes mellitus	4.52e-05	0.00046	CcSEcCtD
Sulfadiazine—Dapsone—CYP3A4—type 2 diabetes mellitus	4.19e-05	0.0163	CrCbGaD
Sulfadiazine—Dapsone—PTGS2—type 2 diabetes mellitus	4.11e-05	0.016	CrCbGaD
Sulfadiazine—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	7.66e-06	0.000354	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	7.66e-06	0.000354	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—NCOA6—type 2 diabetes mellitus	7.61e-06	0.000352	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	7.61e-06	0.000352	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—SLC2A2—type 2 diabetes mellitus	7.52e-06	0.000348	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	7.52e-06	0.000348	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ALDOB—type 2 diabetes mellitus	7.49e-06	0.000347	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—UCP2—type 2 diabetes mellitus	7.48e-06	0.000346	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—UCP3—type 2 diabetes mellitus	7.48e-06	0.000346	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—HSD11B1—type 2 diabetes mellitus	7.48e-06	0.000346	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CPT1A—type 2 diabetes mellitus	7.37e-06	0.000341	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—MTR—type 2 diabetes mellitus	7.37e-06	0.000341	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	7.31e-06	0.000338	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	7.28e-06	0.000337	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	7.25e-06	0.000336	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—NAMPT—type 2 diabetes mellitus	7.23e-06	0.000335	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—HBA1—type 2 diabetes mellitus	7.18e-06	0.000333	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—LIPC—type 2 diabetes mellitus	7.18e-06	0.000333	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GCK—type 2 diabetes mellitus	7.18e-06	0.000333	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP11A1—type 2 diabetes mellitus	7.14e-06	0.00033	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	7.13e-06	0.00033	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	7.05e-06	0.000326	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PCK1—type 2 diabetes mellitus	7.03e-06	0.000326	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—SLC9A1—type 2 diabetes mellitus	7.01e-06	0.000325	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GLP1R—type 2 diabetes mellitus	6.97e-06	0.000322	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CETP—type 2 diabetes mellitus	6.93e-06	0.000321	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	6.93e-06	0.000321	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	6.76e-06	0.000313	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	6.74e-06	0.000312	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	6.74e-06	0.000312	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	6.59e-06	0.000305	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	6.58e-06	0.000305	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	6.51e-06	0.000301	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	6.51e-06	0.000301	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	6.51e-06	0.000301	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	6.51e-06	0.000301	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	6.51e-06	0.000301	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—SLC2A2—type 2 diabetes mellitus	6.5e-06	0.000301	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PSMD6—type 2 diabetes mellitus	6.44e-06	0.000298	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—SNAP25—type 2 diabetes mellitus	6.44e-06	0.000298	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—SREBF1—type 2 diabetes mellitus	6.44e-06	0.000298	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CPT1A—type 2 diabetes mellitus	6.37e-06	0.000295	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—MTR—type 2 diabetes mellitus	6.37e-06	0.000295	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	6.36e-06	0.000294	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	6.36e-06	0.000294	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	6.36e-06	0.000294	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	6.36e-06	0.000294	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CTGF—type 2 diabetes mellitus	6.33e-06	0.000293	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	6.31e-06	0.000292	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—HMGCR—type 2 diabetes mellitus	6.27e-06	0.00029	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—NAMPT—type 2 diabetes mellitus	6.25e-06	0.000289	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	6.21e-06	0.000288	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—HBA1—type 2 diabetes mellitus	6.21e-06	0.000287	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—LIPC—type 2 diabetes mellitus	6.21e-06	0.000287	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GCK—type 2 diabetes mellitus	6.21e-06	0.000287	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP11A1—type 2 diabetes mellitus	6.17e-06	0.000286	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ADRA2A—type 2 diabetes mellitus	6.13e-06	0.000284	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	6.12e-06	0.000283	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	6.1e-06	0.000282	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—SLC9A1—type 2 diabetes mellitus	6.06e-06	0.000281	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CETP—type 2 diabetes mellitus	5.99e-06	0.000277	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	5.96e-06	0.000276	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	5.96e-06	0.000276	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	5.92e-06	0.000274	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP1A2—type 2 diabetes mellitus	5.83e-06	0.00027	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—SLC2A1—type 2 diabetes mellitus	5.83e-06	0.00027	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	5.8e-06	0.000269	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	5.8e-06	0.000269	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	5.74e-06	0.000266	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP3A4—type 2 diabetes mellitus	5.68e-06	0.000263	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	5.67e-06	0.000262	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—SLC2A4—type 2 diabetes mellitus	5.59e-06	0.000259	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GCG—type 2 diabetes mellitus	5.59e-06	0.000259	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.59e-06	0.000259	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PSMD6—type 2 diabetes mellitus	5.57e-06	0.000258	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—SREBF1—type 2 diabetes mellitus	5.57e-06	0.000258	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—SNAP25—type 2 diabetes mellitus	5.57e-06	0.000258	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	5.54e-06	0.000256	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	5.54e-06	0.000256	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	5.54e-06	0.000256	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CTGF—type 2 diabetes mellitus	5.47e-06	0.000253	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—HMGCR—type 2 diabetes mellitus	5.42e-06	0.000251	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.34e-06	0.000247	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	5.31e-06	0.000246	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	5.31e-06	0.000246	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ADRA2A—type 2 diabetes mellitus	5.3e-06	0.000245	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	5.29e-06	0.000245	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	5.19e-06	0.00024	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	5.19e-06	0.00024	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	5.11e-06	0.000236	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	5.11e-06	0.000236	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP2E1—type 2 diabetes mellitus	5.09e-06	0.000236	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	5.09e-06	0.000235	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.06e-06	0.000234	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	5.05e-06	0.000234	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	5.05e-06	0.000234	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	5.05e-06	0.000234	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—SLC2A1—type 2 diabetes mellitus	5.04e-06	0.000233	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP1A2—type 2 diabetes mellitus	5.04e-06	0.000233	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	5.02e-06	0.000232	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	5.02e-06	0.000232	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	4.93e-06	0.000228	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	4.93e-06	0.000228	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	4.93e-06	0.000228	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	4.93e-06	0.000228	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP3A4—type 2 diabetes mellitus	4.91e-06	0.000227	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.89e-06	0.000226	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	4.88e-06	0.000226	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	4.83e-06	0.000224	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	4.83e-06	0.000224	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GNB3—type 2 diabetes mellitus	4.82e-06	0.000223	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.82e-06	0.000223	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—HMOX1—type 2 diabetes mellitus	4.79e-06	0.000222	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CAT—type 2 diabetes mellitus	4.73e-06	0.000219	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	4.64e-06	0.000215	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—APOB—type 2 diabetes mellitus	4.59e-06	0.000213	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.55e-06	0.00021	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	4.53e-06	0.00021	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	4.53e-06	0.00021	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	4.53e-06	0.00021	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTM1—type 2 diabetes mellitus	4.47e-06	0.000207	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	4.45e-06	0.000206	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	4.41e-06	0.000204	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—LPL—type 2 diabetes mellitus	4.38e-06	0.000203	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.35e-06	0.000201	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.34e-06	0.000201	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	4.32e-06	0.0002	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ADCY5—type 2 diabetes mellitus	4.29e-06	0.000199	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GPX1—type 2 diabetes mellitus	4.28e-06	0.000198	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.2e-06	0.000194	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.2e-06	0.000194	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.2e-06	0.000194	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.2e-06	0.000194	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CD36—type 2 diabetes mellitus	4.17e-06	0.000193	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.16e-06	0.000193	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	4.16e-06	0.000193	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	4.15e-06	0.000192	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	4.14e-06	0.000192	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PPP2CA—type 2 diabetes mellitus	4.11e-06	0.00019	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	4.1e-06	0.00019	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	4.1e-06	0.00019	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	4.09e-06	0.000189	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.02e-06	0.000186	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	4e-06	0.000185	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.98e-06	0.000184	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	3.97e-06	0.000184	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—MTHFR—type 2 diabetes mellitus	3.95e-06	0.000183	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	3.93e-06	0.000182	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	3.93e-06	0.000182	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PPARA—type 2 diabetes mellitus	3.87e-06	0.000179	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	3.86e-06	0.000179	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	3.79e-06	0.000175	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—AGT—type 2 diabetes mellitus	3.75e-06	0.000174	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.74e-06	0.000173	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	3.71e-06	0.000172	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	3.7e-06	0.000171	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CALM1—type 2 diabetes mellitus	3.69e-06	0.000171	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—APOE—type 2 diabetes mellitus	3.67e-06	0.00017	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—APOA1—type 2 diabetes mellitus	3.63e-06	0.000168	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	3.6e-06	0.000167	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	3.56e-06	0.000165	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.49e-06	0.000162	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.42e-06	0.000158	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.42e-06	0.000158	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	3.41e-06	0.000158	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	3.39e-06	0.000157	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.39e-06	0.000157	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	3.37e-06	0.000156	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.35e-06	0.000155	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	3.35e-06	0.000155	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.33e-06	0.000154	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.33e-06	0.000154	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.33e-06	0.000154	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	3.33e-06	0.000154	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.31e-06	0.000153	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.25e-06	0.000151	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	3.24e-06	0.00015	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	3.23e-06	0.00015	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.22e-06	0.000149	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PPARG—type 2 diabetes mellitus	3.2e-06	0.000148	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	3.19e-06	0.000148	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	3.18e-06	0.000147	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	3.14e-06	0.000145	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	3.14e-06	0.000145	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—INS—type 2 diabetes mellitus	3.14e-06	0.000145	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	3.08e-06	0.000143	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	3.02e-06	0.00014	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	3.01e-06	0.000139	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.99e-06	0.000138	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.99e-06	0.000138	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.99e-06	0.000138	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.93e-06	0.000136	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	2.93e-06	0.000136	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.91e-06	0.000135	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	2.89e-06	0.000134	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ALB—type 2 diabetes mellitus	2.88e-06	0.000133	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.85e-06	0.000132	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	2.78e-06	0.000129	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	2.77e-06	0.000128	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	2.75e-06	0.000127	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.75e-06	0.000127	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.73e-06	0.000127	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	2.72e-06	0.000126	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	2.71e-06	0.000126	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.7e-06	0.000125	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.7e-06	0.000125	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	2.64e-06	0.000122	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	2.59e-06	0.00012	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.59e-06	0.00012	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.59e-06	0.00012	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	2.59e-06	0.00012	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	2.56e-06	0.000118	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	2.52e-06	0.000117	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	2.49e-06	0.000115	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	2.38e-06	0.00011	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	2.38e-06	0.00011	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	2.25e-06	0.000104	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.23e-06	0.000103	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.23e-06	0.000103	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.22e-06	0.000103	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	2.21e-06	0.000102	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.19e-06	0.000102	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	2.18e-06	0.000101	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.13e-06	9.86e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.07e-06	9.59e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.03e-06	9.41e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	2.02e-06	9.37e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.99e-06	9.22e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.98e-06	9.19e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.94e-06	8.96e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.94e-06	8.96e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.93e-06	8.95e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.91e-06	8.83e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.83e-06	8.48e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.8e-06	8.32e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.77e-06	8.2e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.74e-06	8.05e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.71e-06	7.92e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.7e-06	7.89e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.69e-06	7.8e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.49e-06	6.87e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.46e-06	6.74e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.34e-06	6.18e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.28e-06	5.91e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.28e-06	5.91e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	1.27e-06	5.86e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.17e-06	5.41e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	1.09e-06	5.06e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	8.9e-07	4.12e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	5.87e-07	2.72e-05	CbGpPWpGaD
